InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Kuhlmann Shirley R., Vice-Président Exécutif et Conseiller Juridique. Insider active across 2 companies, notably Collegium Pharmaceutical, INC. In total, 15 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €2.5m. Activity tracked since 10 May 2021. The latest transaction was filed on 4 March 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kuhlmann Shirley R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
40,000 shares@ US$24.0321.0% of flowCommon StockSEC:0001062993-25-004776:0
40,965 shares0Common StockSEC:0001062993-25-002175:0
27,500 shares@ US$21.3413.1% of flowCommon StockSEC:0001062993-25-000761:0
16,848 shares@ US$38.1813.3% of flowCommon StockSEC:0001062993-24-016277:0
24,300 shares@ US$32.548416.6% of flowCommon StockSEC:0001062993-24-011979:0
43,400 shares0Common StockSEC:0001062993-24-003167:0
25,600 shares@ US$15.908.5% of flowCommon StockSEC:0001062993-23-021604:0
16,621 shares@ US$21.65447.6% of flowCommon StockSEC:0001062993-23-014095:0
48,125 shares0Common StockSEC:0001062993-23-003479:0
38,589 shares@ US$18.0716.0% of flowCommon StockSEC:0001062993-22-019618:0
300 shares@ US$20.010.1% of flowCommon StockSEC:0001062993-22-017994:0
734 shares@ US$18.990.0009% mcap7.5% of flowCommon StockSEC:0001062993-22-008131:0
56,700 shares0Common StockSEC:0001062993-22-004319:0
734 shares@ US$19.670.3% of flowCommon StockSEC:0001879789-21-000003:0
7,000 shares@ US$22.773.0% of flowCommon StockSEC:0001192482-21-000419:0
15 of 15 declarations
About Kuhlmann Shirley R.
Kuhlmann Shirley R. is Executive Vice President and General Counsel. She has 15 filings in total, all with COLLEGIUM PHARMACEUTICAL, INC, and the sampled recent filings cover the period from 2021-05-12 to 2025-03-06, with sales of EUR 2469164 and no buys.
